Podcasts about Hepatitis B

Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials.Moderator: Ahmed Elsharkawy Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su WangThis EASL Studio is supported by Aligos Therapeutics and Gilead Sciences Europe Ltd . EASL has received no input from Aligos Therapeutics or Gilead Sciences Europe Ltd with regards to the content of this programme.All EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.

On this week's Tech Nation, Moira speaks with Neuroscientists and Author, Dr. Kelly Clancy joins me to talk about the role that games have played in human development. Her book is “Playing with Reality … How Games Have Shaped Our World.” Then, Dr. Marianne De Backer, CEO of Vir Biotechnology, explains how serious it can be when a person carries both Hepatitis B and Hepatitis D, and what Vir is doing about it.

In this episode, Bright and Anousha spoke with Dr. Nancy Reau from Rush University to share insights and updates on current treatments in development for hepatitis B.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

The Medicare Advantage Minute is pre-empted so that we can spend the time examining the current state of Part D Prescription Drug Plans (PDP).  We also do some speculation about the economic pressures facing these plans and what changes might be necessary for the year 2026. In the "Your Medicare Benefits 2024" we learn the eligibility requirements and the extent to which Medicare will cover Hepatitis B screening and treatment. Finally, a quiz reveals the healthiest states vs. the unhealthiest states in the USA for older Americans. Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COVID pivot into infectious diseases (Hepatitis Delta and Hepatitis B) and oncology (solid tumors), how he reprioritized the company's development candidates and assimilated Sanofi's acquired T cell engager platform, and his own transition from healthcare provider to clinical research. This episode is brought to you by Avantor. For more information, visit avantorsciences.comAccess this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

What if everything you've heard about vaccines is wrong? Or maybe just wildly misunderstood? Dr. John, a Canadian internist who works at a major teaching hospital, joins us to cut through the noise and explain what's really happening with vaccine misinformation.From the fascinating origins of vaccines (did you know the word comes from "vacca" meaning cow?) to the most persistent myths circulating today, Dr. John provides clear, evidence-based explanations that make complex immunology accessible. We dive deep into why Andrew Wakefield's infamous autism study was retracted, how the "turbo cancer" conspiracy theory defies basic science, and why giving Hepatitis B vaccines to infants makes perfect sense despite what critics claim.The conversation takes unexpected turns as we explore how anti-vaccine narratives exploit normal death rates to create fear, why RFK Jr.'s definition of autism is wildly inaccurate, and how the difference between long and short incubation viruses explains why some vaccines seem more effective than others. Dr. John even explains how the "died suddenly" narrative falls apart when you apply simple analytical methods to the data.Most powerfully, we confront the common argument of "what did people do before vaccines?" with the stark reality: they died, often in massive numbers. This eye-opening discussion reveals how herd immunity protects the most vulnerable among us and why maintaining high vaccination rates matters for everyone, not just those receiving the vaccine.Whether you're curious about vaccine science, concerned about misinformation, or just want to understand how to evaluate health claims critically, this episode provides the tools to separate fact from fiction in an increasingly confusing information landscape. Follow Dr. John on social media @dr.john.l on TikTok and @dr.john.lx on Instagram for more science-based insights that cut through the noise. Support the showYou can find us on social media here:Rob TiktokRob InstagramLiam TiktokLiam Instagram

In this MM+M Fast Break, Pharma Editor Lecia Bushak talks with Dynavax chief medical officer Rob Janssen about the company's latest survey on Hepatitis B vaccination, as well as what medical marketers should keep in mind when it comes to the current vaccine messaging landscape. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

This week's episode takes a closer look at what's often left unsaid about vaccines before they're administered. I'm joined by Alexandra from Just the Inserts, who specializes in interpreting medical documents and decoding the fine print. Together, we break down what true informed consent should look like, discuss the history of vaccination, and examine the inserts for TDAP (during pregnancy), RSV, Hepatitis B (for infants), and the vitamin K shot at birth. We also explore contraindications, alternatives to vitamin K, and considerations for more individualized vaccine schedules. Click HERE to access today's shownotes.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431 Overview: Tune in as we discuss the updated WHO and CDC hepatitis B guidelines, specifically focusing on screening, vaccination, and management. Learn how to apply these recommendations in clinical practice to support the WHO's goal to eliminate hepatitis B by 2030. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-431 Overview: Tune in as we discuss the updated WHO and CDC hepatitis B guidelines, specifically focusing on screening, vaccination, and management. Learn how to apply these recommendations in clinical practice to support the WHO's goal to eliminate hepatitis B by 2030. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis. However, hepatitis is often caused by a virus. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. ​Hepatitis D, also known as “delta hepatitis,” is a liver infection caused by the hepatitis D virus (HDV). Hepatitis D only occurs in people who are also infected with the hepatitis B virus. Hepatitis D is spread when blood or other body fluids from a person infected with the virus enters the body of someone who is not infected. Hepatitis D can be an acute, short-term infection or become a long-term, chronic infection. Hepatitis D can cause severe symptoms and serious illness that can lead to life-long liver damage and even death. People can become infected with both hepatitis B and hepatitis D viruses at the same time (known as “coinfection”) or get hepatitis D after first being infected with the hepatitis B virus (known as “superinfection”). There is no vaccine to prevent hepatitis D. However, prevention of hepatitis B with hepatitis B vaccine also protects against future hepatitis D infection. ​Hepatitis E is a liver infection caused by the hepatitis E virus (HEV). HEV is found in the stool of an infected person. It is spread when someone unknowingly ingests the virus – even in microscopic amounts. In developing countries, people most often get hepatitis E from drinking water contaminated by feces from people who are infected with the virus. In the United States and other developed countries where hepatitis E is not common, people have gotten sick with hepatitis E after eating raw or undercooked pork, venison, wild boar meat, or shellfish. In the past, most cases in developed countries involved people who have recently traveled to countries where hepatitis E is common. Symptoms of hepatitis E can include fatigue, poor appetite, stomach pain, nausea, and jaundice. However, many people with hepatitis E, especially young children, have no symptoms. Except for the rare occurrence of chronic hepatitis E in people with compromised immune systems, most people recover fully from the disease without any complications. No vaccine for hepatitis E is currently available in the United States. (credits CDC)

Send us a textIn this conversation, Dr. Paul Offit and pediatrician Jessica Hochman discuss the importance of vaccinations, the challenges of vaccine hesitancy among parents, and the need for nuanced conversations in public health. They explore the impact of the COVID-19 pandemic on public trust, and the science behind vaccination schedules. The discussion emphasizes the importance of understanding parental concerns while advocating for the safety and efficacy of vaccines. About Paul A. Offit, MD!Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, and a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines.He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, a Research Career Development Award from the National Institutes of Health, and the Sabin Vaccine Institute Gold Medal.Dr. Offit has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC. For this achievement, Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases, and he was honored by Bill and Melinda Gates during the launch of their Foundation's Living Proof Project for global health.In 2009, Dr. Offit received the President's Certificate for Outstanding Service from the American Academy of Pediatrics. In 2011, he received the Humanitarian of the Year Award from the BiologicDr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. For more content from Dr Jessica Hochman:Instagram: @AskDrJessicaYouTube channel: Ask Dr JessicaWebsite: www.askdrjessicamd.com-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com.The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

Hear from Lou Kassa, CEO of the Hepatitis B Foundation, Blumberg Institute, and Pennsylvania Biotechnology Center, and Chari Cohen, President of the Hepatitis B Foundation in an interview for our podcast as they discuss what these changes mean for our organizations and others like us. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Babies receive a shocking number of vaccines in the first year of life. This episode covers the Hepatitis B, Rotavirus, and Polio vaccines.This is installment 3 of our intermittent series on vaccines. You can find the first here: https://rumble.com/v6lk9ka-the-vaccine-conversation-s5-ep17.html?e9s=src_v1_ucp The second here: https://rumble.com/v6qw46q-adolescent-vaccines-hpv-and-meningococcal-s6-ep2.html?e9s=src_v1_ucp And here, you can find a list of vaccine research resources Abby has compiled and continues to update as she continues her research: https://docs.google.com/document/d/1ctSD3J4I-aVNO3JSeopqIXRZkXDdUq4NhqgubGxHN4s/edit?usp=sharing ---------- Support the show and get bonus UNHINGED episodes ---------- LOCALS - https://conspiracypilled.locals.com/ MERCH - https://conspiracypilled.com/collections/all Join the DISCORD - https://discord.gg/c8Acuz7vC9 Give this podcast a 5 Star Review - https://ratethispodcast.com/conspiracypilled ---------- SPONSOR ---------- NORTH ARROW COFFEE - https://northarrowcoffee.co Use code CONSPIRACY10 to get 10% off your order! ------- FOLLOW THE HOSTS ------- Abby — @abbythelibb_ on X and InstagramLiz —- @adelethelaptop on XJon —- @Kn0tfersail on XMusic by : Tyler Daniels Become a supporter of this podcast: https://www.spreaker.com/podcast/conspiracy-pilled--6248227/support.

On today's Quick Start podcast: NEWS: Nightclub Collapse in Santo Domingo – 44 dead and over 150 injured after a roof collapse at Jet Set nightclub; former MLB pitcher Octavio Dotel among the victims. New Theory on Mount Sinai – Scholars suggest Mount Sinai may be in Saudi Arabia, not Egypt, with growing support for Jabal al-Lawz as the true biblical site. FOCUS STORY: Phil Robertson is battling Hepatitis B, and his family is asking for prayer. While his diagnosis is serious, Phil says he's at peace. Meanwhile, daughter Sadie is expecting her second child and says the family is holding tightly to their faith. THE MAIN THING: Cassidy Carlisle, a senior varsity athlete in Maine, is speaking out after competing against a transgender athlete. Her story highlights the growing national debate over fairness in women's sports and the importance of protecting female athletic spaces. TODAY'S VERSE: Isaiah 40:29 – “He gives strength to the weary and increases the power of the weak.” SHOW LINKS JESUS AND THE PROPHECIES OF CHRISTMAS : https://podcasts.apple.com/us/podcast/jesus-and-the-prophecies-of-christmas/id1783607035 NEWSMAKERS POD: https://podcasts.apple.com/us/podcast/newsmakers/id1724061454 DC DEBRIEF POD: https://podcasts.apple.com/au/podcast/d-c-debrief/id1691121630 CBN News YouTube: https://www.youtube.com/@CBNnewsonline CBN News https://www2.cbn.com/news Faithwire https://www.faithwire.com

In this episode, we welcomed Heidi Emery and Kathryn Jack to discuss their qualitative review on the barriers and facilitators of hepatitis B programs and services for prison inmates. Read more about their research here: https://pubmed.ncbi.nlm.nih.gov/39731473/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Yao-Chun (Holden) Hsu from School of Medicine and Graduate Institute of Medicine, I-Shou University, Kaohsiung, Taiwan, on the paper "Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B" published in paper copy in Gut in April 2025.   Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p).

This week, Marianna sits down with John Faragon to discuss latent TB management and the Hepatitis B vaccine. Tune in to learn all about how the opportunistic infections guidelines have changed and how this affects people with HIV. -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

In Ausgabe 99 sprechen Kabarettist Martin Puntigamund Ursula Hollenstein, Infektiologin & Fachärztin für Reisemedizin darüber, was man unter STD versteht, worum es sich bei Venerologie handelt, was Venus mit Geschlechtskrankheiten zu tun hat, warum Chlamydien ihre Karriere ohne viel Aufsehen machen, weshalb Selbsttests helfen könnten, wieso die Klobrille so oft als Ausrede bei der Ansteckung mit Geschlechtskrankheiten herhalten muss, warum das Kondom ein Tausendsassa ist, wie Bakterien Antibiotika-Resistenzen entwickeln, warum das die Behandlung nicht nur schwerer, sondern auch teurer macht, weshalb Geschlechtskrankheiten heute wieder häufiger auftreten, was besser ist – harter oder weicher Schanker, warum Syphilis ab einem gewissen Zeitpunkt unheilbar wird, weshalb Syphilis die Spanische Grippe der Geschlechtskrankheiten ist, warum Nonnen mitverantwortlich für die Entdeckung von HPV waren, dass manche Eltern glauben, erst die Impfung gegen eine Geschlechtskrankheiten bringt ihre Kinder auf sexuelle Gedanken, wo Herpes zwischen zwei Fieberblasenausbrüchen wohnt, weshalb man sich über einen Strauß Gürtelrosen nicht freut, seit wann HIV kein Todesurteil mehr bedeutet, warum der Erfolg der HIV-Therapien paradoxerweise den Erfolg des Virus befeuert, wieso Hepatitis A und B nur ähnlich heißen, aber nicht verwandt sind, weshalb sich Tiere nicht gegen Hepatitis B impfen lassen müssen, warum wahnsinnige Regierungen wie in den USA mit ihren Maßnahmen mithelfen, Millionen Menschen auf der ganze Welt zu töten, wieso die Affen mit Pocken nichts mehr zu tun haben wollen, warum man aufs Bonjour-Tröpfchen nicht anstoßen sollte & wieso nicht nur Pauli-Fans jubeln, wenn HSV verliert.

In this episode, Bright and Anousha invited Michaela Jackson, Program Director of Prevention and Policy at the Hepatitis B Foundation to share insights about the hepatitis B vaccine and why it must be prioritized. Learn more about birth dose and hepatitis B vaccination: https://www.hepb.org/resources-and-support/hep-b-birth-dose-media-toolkit/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Es gibt bestimmte Risikogruppen, bei denen eine Hepatitis-Testung besonders sinnvoll ist, sagt Allgemeinmediziner Dr. Christoph Schuler. In seiner Hausarztpraxis mit infektiologischem Schwerpunkt betreut er Personen, die genau in diese vulnerablen Gruppen fallen. In dieser Folge berichtet er, welche Hinweise schon in der Anamnese zu finden sind und was bei der Therapie der virusinduzierten Formen beachtet werden muss.

Fáilte ar ais chuig eagrán nua de Ar An Lá Seo ar an 20ú lá de mí Eanair, liomsa Lauren Ní Loingsigh. I 1978 chuaigh an praghas suas de phrátaí de bharr smuglaeireacht. Dúirt ceannaí I mBaile Átha Cliath nach raibh aon phrátaí ann mar go raibh costas an tonna 140 punt do mhórdhíola agus ceithre phunt do mhála ceithre chloch. I 1986 tuairisc cheithre cás AIDS eile I bpríosún Mountjoy. Bhí 47 gcás ann ag an am. Fuair stáisiúin na nGardaí trealamh cosanta, agus fuair siad vacsaín Hepatitis B. Chabhraigh An Roinn Dlí agus Cirt le cainteanna oideachasúil. I 1986 fuair Mick Hennessy bás in Ospidéal Inis nuair a bhí sé tinn. Bhí ina hochtóidí agus bhí sé imreoir iománaíocht den scoth. Chomh maith bhí sé mar rúnaí den chlub ó 1934 go dtí 1950. I 1992 bhí easpa uisce I gCora Chaitlín, chomh maith leis sin bhí caighdeán an uisce uafásach. Chuir na daoine a raibh ina chónaí sa bhaile cheist ar Chomhairle Chontae an Chláir chun cabhrú leo mar go raibh an t-uisce dainséarach. Sin Queen le Bohemian Rhapsody an t-amhrán is mó ar an lá seo I 1976. Ag lean ar aghaidh le nuacht cheoil ar an lá seo I 2001 bhí seirbhís chuimhneacháin do Kirsty MacColl a fuair bás nuair a bhí sí I Meicsiceo an bhliain roimhe. Bhí Bono ó U2 ann agus Billy Bragg. I 2022 fuair Meat Loaf bás ag aois 74. An t-ainm a bhí air ná Marvin Lee Aday agus bhí clú agus cáil air dá guth a bhí aige. Agus ar deireadh breithlá daoine cáiliúla ar an lá seo rugadh Buzz Aldrin I Meiriceá I 1930 agus rugagh aisteoir Evan Peters ar an lá seo I Meiriceá I 1987 agus seo chuid de na rudaí a rinne sé. Beidh mé ar ais libh amárach le heagrán nua de Ar An Lá Seo.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EWQ865. CME/MOC/NCPD/AAPA credit will be available until December 17, 2025.Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hepatitis B Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Join us as Paul and Watto reflect on the past year, discussing some favorite insights gained covering a range of topics, including dental pain management, cardiac amyloidosis, the impact of continuous glucose monitoring on diabetes care, the complexities of diagnosing primary hyperparathyroidism, hepatitis B screening and vaccination, GLP-1 agonists, travel medicine, endometriosis, rhinitis, and recurrent UTIs.  Plus, we feature listener voicemails sharing their favorite episodes and why they love the Curbsiders! No CME for this episode, but claim CME for past shows at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Introduction and Year-End Reflections 02:59 Picks of the Year 05:53 Dental Pain and Oral Care Insights 10:25 Cardiac Amyloidosis 14:33 Listener mail- diabetes 16:33 Neck Pain 19:08 Continuous Glucose Monitoring in Diabetes 23:57 Hyperparathyroidism 30:48  Hepatitis B  34:01 Listener mail- obesity 36:14 Travel Medicine: Malaria, Diarrhea, and Vaccination 40:38 Endometriosis 46:08 Rhinitis and Environmental Allergies 49.24  Recurrent UTIs 55:08 Reflections on Nine Years of Curbsiders Credits Written, Produced, and hosted by: Matthew Watto MD, FACP; Paul Williams MD, FACP Cover Art: Matthew Watto MD, FACP Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Molly Heublein MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Sponsor: AquaTru Today listeners receive 20% OFF any AquaTru purifier! Just go to AquaTru.com and enter code “CURB“ at checkout.   Sponsor: Freed Visit Freed.ai. Use code CURB50 to get $50 off your first month. Sponsor: Quince Go to Quince.com/curb for 365-day returns, plus free shipping on your order! 

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hepatitis B Virus⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Microbiology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Today's Guest Jamie-Lynn Sigler has been acting and singing since the age of 7. She got her start in New York regional theater, and has since starred in over two dozen theatrical productions including "Annie," "The Wizard of Oz," "The Sound of Music," "The Wiz," and "Gypsy." In the summer of 2001, she starred in the touring production of Richard Rodgers and Oscar Hammerstein II's "Cinderella," playing the lead opposite Eartha Kitt. Jamie made her Broadway debut starring as Belle in Disney's Broadway production of "Beauty and the Beast" from October of 2002 through February 2003. Beyond her theatrical appearances, she starred as Meadow Soprano in the critically acclaimed HBO original series The Sopranos (1999). For her work on the show, she received the 1999 and 2000 Hollywood Reporter Young Star Awards for Best Young Actress in a Dramatic Television Series and both 2001 and 2002 ALMA nominations. She also has a SAG Award for The Sopranos (1999) Best Ensemble Cast. Jamie is taking Kesimpta (ofatumumab) for her RMS. As with any medication, there can be risks. Doctors will test patients for active Hepatitis B infection, as people with Hepatitis B shouldn't take KESIMPTA. A doctor will also discuss the potential for serious side effects such as life-threatening and fatal infections, injection reactions, lowered antibodies, and other common ones like headaches. Links from Jamie ReframingMS.com TreatmentDecisionGuide.com, is a decision guide Jamie co-created with Novartis and others living with MS to provide people with detailed questions to ask an MS specialist to get to an informed treatment decision. MeSsy podcast Not Today, Pal podcast About Dr. Raj Dr Raj is a quadruple board certified physician and associate professor at the University of Southern California. He was a co-host on the TNT series Chasing the Cure with Ann Curry, a regular on the TV Show The Doctors for the past 7 seasons and has a weekly medical segment on ABC news Los Angeles. More from Dr. Raj www.BeyondThePearls.net The Dr. Raj Podcast Dr. Raj on Twitter Dr. Raj on Instagram Want more board review content? USMLE Step 1 Ad-Free Bundle Crush Step 1 Step 2 Secrets Beyond the Pearls The Dr. Raj Podcast Beyond the Pearls Premium USMLE Step 3 Review MedPrepTGo Step 1 Questions Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode discusses four MMWR reports. First, a CDC study finds that 1 in 20 women surveyed experienced intimate partner violence during pregnancy. Second, a CDC report on waterborne disease outbreaks linked to splash pads highlights ways to stay healthy while you play. Third, overdose deaths overall and with illegally made fentanyls detected started to decline in late 2023; overdose deaths with carfentanil increased sharply but remain rare. Last, CDC vaccination recommendations for hepatitis B were updated to include an additional vaccine option during pregnancy.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/STZ865. CME/MOC credit will be available until December 16, 2025.In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/STZ865. CME/MOC credit will be available until December 16, 2025.In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/STZ865. CME/MOC credit will be available until December 16, 2025.In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/STZ865. CME/MOC credit will be available until December 16, 2025.In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/STZ865. CME/MOC credit will be available until December 16, 2025.In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

In this episode, Anousha and Bright invited Dr. Robert Gish to speak about hepatitis B Reactivation, a serious health issue often overlooked in the discourse surrounding hepatitis B and liver cancer.Learn more about Dr. Gish at his website www.robertgish.com as well as through his podcast linked below.  Everything Liver Podcast: https://www.robertgish.com/podcastSupport the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

ICAN lead counsel, Aaron Siri, Esq., guides you through an exploration of the Hepatitis B vaccine, outlining the serious problems with this controversial vaccine given to newborn babies in their first days of life in the US, per the CDC. Hear why ICAN is fighting to have this shot removed from the childhood schedule. Further, ICAN is standing up to hospitals which vaccinate newborns without consent of the parents. You can support his effort at icandecide.org/legalmatch.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Kenneth Sherman of Massachusetts General Hospital and Harvard Medical School about the possibility of a cure for hepatitis B. The World Health Organization estimates that 254 million people were living with chronic hepatitis B globally in 2022. Dr Saag and Dr Sherman discuss the lifecycle of hepatitis B including the role that covalently closed circular DNA (cccDNA) plays in the hepatitis B virus (HBV) replication cycle. Dr Sherman defines functional cure and provides an overview of the most promising cure strategies. They also discuss whether antiretroviral drugs like tenofovir, used in the treatment of HIV, can contribute toward a functional cure of hepatitis B. Dr Sherman discusses other strategies like capsid assembly modulators (CAMs), monoclonal antibodies, and toll-like receptor (TLR) agonists. Finally, they discuss the effectiveness of the hepatitis B vaccine in prevention and look forward to the future by considering a timeline for a cure based on the status of ongoing clinical trials. 0:00 – Introduction1:23 – Overview of the lifecycle of hepatitis B 5:29 – Discussion of the most promising cure strategies7:11 – Defining functional cure10:56 – The role of drugs like tenofovir in a functional cure 13:39 – Targets that can affect viral production 16:04 – Potential of capsid assembly modulators (CAMs)18:03 – Other strategies like immune modulators and monoclonal antibodies22:29 – Interest in toll-like receptor (TLR) agonists and therapeutic vaccines24:32 – Outlook for the future and the effectiveness of a hepatitis B vaccine in prevention __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from November 9-15, 2024.

In this episode, Anousha invited Mohamed Ali, a public health professional with the Seattle King County Health Department as well as a board member with Somali Health Board. Mohamed shared his experience working on the liver cancer disparities project and educating Somali communities in Seattle about the link between hepatitis B and liver cancer. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode Dr. Kharrazian explores the world of chronic infections, such as Epstein-Barr Virus (EBV), Hepatitis C, Covid, and Human Cytomegalovirus (CMV), and their impact on our immune system. He explores how some pathogens hide within our bodies and reemerge when our immunity is compromised.He discusses the latest research linking these infections to autoimmune diseases and even cancer, and emphasizes the importance of enhancing our immune defenses rather than just relying on antiviral treatments. He covers a wide range of topics from the basics of virology, the dynamics of long COVID, and the sobering realities of Hepatitis C and Human Papillomavirus (HPV), to the ripple effects of viral infections on our overall health.Learn more at drknews.comFor patient-oriented courses, visit https://drknews.com/online-courses/For CE and CME practitioner courses, visit https://kharrazianinstitute.com/00:00 MHC proteins activate cells to fight infection.06:16 Long COVID factors: comorbidities, age, severity, inflammation, genetics13:50 Viral infection can trigger chronic inflammatory conditions.17:27 Long COVID linked to persistent antinuclear antibodies.22:53 Autoantibodies may form due to SARS-CoV-2 infection.27:28 Hepatitis B virus vaccine increases MS risk.33:58 Alphaviruses include herpes, 53% exhibit antibodies.39:30 Cytomegalovirus linked to autoimmune diseases, immune manipulation.45:39 Chronic Epstein Barr causes inflammation, cancer risk.52:02 Hepatitis C symptoms: diverse and system-wide impacts.57:33 High treatment costs spark global protests, denials.01:00:33 PCR measures viral load; biomarkers assess liver damage.01:06:08 Identify underlying health issues causing recurring infections.Support this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Bright spoke with Prince--a patient advocate living with hepatitis B. Prince details his journey with hepatitis B and his aspirations to eliminate hepatitis B and improve the quality of life of those living with hepatitis B. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Tras motín en Cereso Morelos  investigan a altos mandos por corrupción Rusia por error derribó uno de sus aviones de combateMás información en nuestro podcast

In this podcast episode, we interview Dr. Julia Beatty, a distinguished Professor of Veterinary Medicine and Infectious Diseases at City University's Jockey Club College of Veterinary Medicine and Life Sciences. Dr. Beatty shares her remarkable journey from studying at University College London and the Royal Veterinary College to her extensive work in feline medicine and infectious diseases. She discusses her career milestones, including her PhD in feline virology at the University of Glasgow, her leadership roles at the University of Sydney, and her contributions to the field through various boards and editorial positions. Dr. Beatty also offers insights into her research, her passion for feline medicine, and the future of veterinary infectious diseases.Hepatitis B-like viruses (hepadnaviruses) have been identified in a wide range of animals, including cats. The hepadnavirus in cats, sometimes referred to as feline hepadnavirus or FeHBV, is similar to the human hepatitis B virus but is specific to felines.This virus is a relatively recent discovery, and researchers like Dr. Julia Beatty have been at the forefront of studying it. FeHBV has been found in domestic cats, and while the full impact on feline health is still being explored, there is concern that it could contribute to liver disease in cats, much like its human counterpart does in people.The discovery of FeHBV has opened new avenues for research in feline medicine, particularly in understanding liver diseases in cats and the potential for transmission and prevention. As research continues, it may lead to better diagnostic and treatment options for cats affected by this virus.

Become a pro in Hepatitis B! Dr. Arthur Kim teaches us how to approach Hepatitis B screening and vaccination in primary care, provides pearls on counseling patients with chronic Hepatitis B infection, and summarizes considerations for Hepatitis B antiviral treatment and monitoring. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case from Kashlak Hepatitis B screening - who should be screened? Hepatitis B screening - interpreting test results Hepatitis B vaccination Stages of Chronic HBV infection Counseling patients with chronic HBV about preventing transmission and protecting liver health Treatment of chronic HBV infection Screening for hepatocellular carcinoma Outro Credits Producer, Writer, Show Notes, Infographics, and Cover Art: Malini Gandhi  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Fatima Syed MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Arthur Kim MD Sponsor: Babbel Get up to 60% off your Babbel subscription Babbel.com/curb Sponsor: Freed You can try Freed for free by going to freed.ai. Use code CURB50 for $50 off your first month.  Sponsor: Pattern Request your disability insurance quotes with Pattern at patternlife.com/curbsiders.

In perhaps one of the largest medical scandals in the UK, thousands of hemophiliacs were given serious diseases when they unknowingly received tainted blood products. Without their knowledge, these people received blood from HIV positive, Hepatitis B,C and A positive donors who were sex workers and prisoners. We look into this rare moment where the public, legacy media, and over 180 politicians are aligned to bring justice for the victims.